The long-term effect of menopause on postmenopausal bone loss in Japanese women: Results from a prospective study

被引:46
|
作者
Okano, H
Mizunuma, H
Soda, M
Kagami, I
Miyamoto, S
Ohsawa, M
Ibuki, Y
Shiraki, M
Suzuki, T
Shibata, H
机构
[1] Gunma Univ, Sch Med, Dept Obstet & Gynecol, Gunma 371, Japan
[2] Res Inst & Practice Involut Dis, Nagano, Japan
[3] Tokyo Metropolitan Inst Gerontol, Dept Epidemiol, Tokyo, Japan
关键词
D O I
10.1359/jbmr.1998.13.2.303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study ws to elucidate perimenopausal bone loss in relation to menstrual conditions and to investigate the long-term effect of menopause on bone loss in aged women. The rate of change in bone mineral density (BMD) was measured twice at an exact interval of 12 months by dual-energy X-ray absorptiometry (DXA) at the lumbar spine in 176 pre-and postmenopausal healthy women 41-65 years of age. Serum follicle-stimulating hormone, intact and N-fragment osteocalcin (OC), three types of vitamin D-3, parathyroid hormone (PTH), and calcitonin were also determined. Women who exercised regularly or had anatomical changes at the lumbar spine were excluded from this study. The subjects were divided into eight groups based on their menstrual status and years since menopause. Annual bone loss at the lumbar spine of premenopausal women with regular menstruation was -0.2 +/- 1.9% (95% confidence interval, -0.9 similar to-0.4%) and was not statistically different from zero, while that of women with irregular menstruation or at menopausal transition,vas -2.1 +/- 3.4% (-3.4 similar to-0.8%), and -3.3 +/- 2.3% (-5.2 similar to-0.3%), respectively, and was significantly different from zero. Serum OC levels of women at menopausal transition were significantly higher than those of women with regular menstruation, suggesting that bone loss had commenced in these women. The rate of annual change in BMD of women who were menopausal for 1-3, 4-6, 10-12, and more than 13 years was -3.1 +/- 4.0% (-4.7 similar to-1.5%), -1.2 +/- 2.6% (-2.2 similar to-0.2%), -1.0 +/- 3.0% (-2.3 similar to-0.3%), and -2.3 +/- 2.1% (-3.7 similar to-1.0%), respectively, and was significantly less than zero. But the annual bone loss of women who were menopausal for 7-9 years was -1.5 +/- 2.6% (-3.0 similar to-0.1%) and was not statistically significant from zero. These results indicate that postmenopausal women lose BMD in two phases. The early bone loss is rapid and commences during irregular menstruation, then is attenuated within 6 years after the onset of menopause. The second bone loss commences after the attenuation of the first bone loss. Among bone metabolic hormones, intact PTH alone showed an age-related increase and was suggested as being a causal factor of bone loss in women who were menopausal for 13 years or more.
引用
收藏
页码:303 / 309
页数:7
相关论文
共 50 条
  • [41] Age, menopause, bone turnover markers and lumbar bone loss in healthy Japanese women
    Iki, M
    Kajita, E
    Dohi, Y
    Nishino, H
    Kusaka, Y
    Tsuchida, C
    Yamamoto, K
    Ishii, Y
    MATURITAS, 1996, 25 (01) : 59 - 67
  • [42] Bone Loss in Long-Term Survivors after Transplantation of Hematopoietic Stem Cells: A Prospective Study
    C. Schulte
    D. W. Beelen
    U. W. Schaefer
    K. Mann
    Osteoporosis International, 2000, 11 : 344 - 353
  • [43] Bone loss in long-term survivors after transplantation of hematopoietic stem cells: A prospective study
    Schulte, C
    Beelen, DW
    Schaefer, UW
    Mann, K
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 (04) : 344 - 353
  • [44] Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: The OFELY study
    Garnero, P
    Mulleman, D
    Munoz, F
    Sornay-Rendu, E
    Delmas, PD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (10) : 1789 - 1794
  • [45] Effect of long-term treatment with raloxifene on mammary density in postmenopausal women
    Lasco, Antonino
    Gaudio, Agostino
    Morini, Elisa
    Morabito, Nancy
    Nicita-Mauro, Claudio
    Catalano, Antohino
    Denuzzo, Giulia
    Sansotta, Carlo
    Xourafa, Anastasia
    Macri, Ilaria
    Frisina, Nicola
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (05): : 787 - 792
  • [46] Effect of long-term hormone therapy on telomere length in postmenopausal women
    Lee, DC
    Im, JA
    Kim, JH
    Lee, HR
    Shim, JY
    YONSEI MEDICAL JOURNAL, 2005, 46 (04) : 471 - 479
  • [47] THE EFFECT OF LONG-TERM MELATONIN SUPPLEMENTATION ON PSYCHOSOMATIC DISORDERS IN POSTMENOPAUSAL WOMEN
    Chojnacki, C.
    Kaczka, A.
    Gasiorowska, A.
    Fichna, J.
    Chojnacki, J.
    Brzozowski, T.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 69 (02): : 297 - 304
  • [48] Characteristics of Long-Term Femoral Neck Bone Loss in Postmenopausal Women: A 25-Year Follow-Up
    Moilanen, Anna
    Kopra, Juho
    Kroger, Heikki
    Sund, Reijo
    Rikkonen, Toni
    Sirola, Joonas
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (02) : 173 - 178
  • [49] Sleep in postmenopausal women: Different response to hormone replacement therapy between short-term and long-term menopause
    Campos, HH
    Baracat, EC
    Bittencourt, LA
    Tufik, S
    SLEEP, 2003, 26 : A166 - A167
  • [50] LONG-TERM EFFECTS OF TRANSDERMAL AND ORAL HORMONE REPLACEMENT THERAPY ON POSTMENOPAUSAL BONE LOSS
    HILLARD, TC
    WHITCROFT, SJ
    MARSH, MS
    ELLERINGTON, MC
    LEES, B
    WHITEHEAD, MI
    STEVENSON, JC
    OSTEOPOROSIS INTERNATIONAL, 1994, 4 (06) : 341 - 348